)
)
Lipum Investor Relations Material
Latest events
Q3 2024
Lipum
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Lipum
Access all reports
Lipum AB, a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases. The company focuses on developing small molecule inhibitors of G protein-coupled receptors that regulate inflammation through modulation of intracellular trafficking pathways and other mechanisms. The company is based in Umeå, Sweden.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
LIPUM
Country
🇸🇪 Sweden